Effect of a chimeric antibody targeting CXCL1 in bladder cancer

被引：0
|
作者：
Kim, Nari
Furuya, Hideki
Murakami, Kaoru
Rosser, Charles J.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1524
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of a first-in-class humanized antibody targeting CXCL1 in bladder cancer
    Murakami, Kaoru
    Sasaki, Yuka
    Furuya, Hideki
    Rosser, Charles
    CANCER RESEARCH, 2022, 82 (12)
  • [2] DEVELOPMENT OF A FIRST-IN-CLASS HUMANIZED ANTIBODY TARGETING CXCL1 IN BLADDER CANCER
    Murakami, Kaoru
    Sasaki, Yuka
    Furuya, Hideki
    Rosser, Charles
    JOURNAL OF UROLOGY, 2021, 206 : E729 - E729
  • [3] Chemokine CXCL1 in bladder cancer
    Koufou, S. V.
    Wieland, W. F.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2010, 89 : 68 - 68
  • [4] CXCL1 is elevated in the urine of bladder cancer patients
    Burnier, Andre
    Shimizu, Yoshiko
    Dai, Yunfeng
    Nakashima, Masakazu
    Matsui, Yoshiyuki
    Ogawa, Osamu
    Rosser, Charles J.
    Furuya, Hideki
    SPRINGERPLUS, 2015, 4
  • [5] Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer
    Kawanishi, Hiroaki
    Matsui, Yoshiyuki
    Ito, Masaaki
    Watanabe, Jun
    Takahashi, Takeshi
    Nishizawa, Koji
    Nishiyama, Hiroyuki
    Kamoto, Toshiyuki
    Mikami, Yoshiki
    Tanaka, Yoshinori
    Jung, Giman
    Akiyama, Hideo
    Nobumasa, Hitoshi
    Guilford, Parry
    Reeve, Anthony
    Okuno, Yasushi
    Tsujimoto, Gozoh
    Nakamura, Eijiro
    Ogawa, Osamu
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2579 - 2587
  • [6] Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer
    Nakashima, Masakazu
    Matsui, Yoshiyuki
    Kobayashi, Takashi
    Saito, Ryoichi
    Hatahira, Satoko
    Kawakami, Kazumi
    Nakamura, Eijiro
    Nishiyama, Hiroyuki
    Ogawa, Osamu
    CANCER BIOMARKERS, 2015, 15 (04) : 357 - 364
  • [7] Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity
    Al Aameri, Raheem F. H.
    Alanisi, Entkhab M. A.
    Oluwatosin, Adu
    Al Sallami, Dheyaa
    Sheth, Sandeep
    Alberts, Ian
    Patel, Shree
    Rybak, Leonard P. P.
    Ramkumar, Vickram
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] THE POTENTIAL UTILITY OF CHEMOKINE CXCL1 (GROa) AS A NOVEL DIAGNOSTIC AND PROGNOSTIC MARKER FOR BLADDER CANCER
    Kobayashi, Takashi
    Matsui, Yoshiyuki
    Sunada, Takuro
    Inoue, Takahiro
    Kamba, Tomomi
    Ogawa, Osamu
    JOURNAL OF UROLOGY, 2015, 193 (04): : E482 - E482
  • [9] Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2
    Killian, Peter H.
    Kronski, Emanuel
    Michalik, Katharina M.
    Barbieri, Ottavia
    Astigiano, Simonetta
    Sommerhoff, Christian P.
    Pfeffer, Ulrich
    Nerlich, Andreas G.
    Bachmeier, Beatrice E.
    CARCINOGENESIS, 2012, 33 (12) : 2507 - 2519
  • [10] MicroRNA-873 inhibits proliferation and induces apoptosis by targeting CXCL1 in gastric cancer
    Chen, Xuyan
    Chen, Renpin
    Wu, Wei
    Huang, Zhiming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10011 - 10019
12345